carmustine has been researched along with Adenocarcinoma in 65 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The ability of lonidamine (LND), an energolytic derivative of indazole carboxylic acid, to modulate the cytotoxic activity of mitomycin C (MMC) and 1,3,bis(2-chloroethyl)-1-nitrosourea (BCNU) was investigated in two human adenocarcinoma cell lines (LoVo and HT29) expressing different sensitivity profiles to the drugs." | 7.69 | In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells. ( Bearzatto, A; Costa, A; Orlandi, L; Silvestrini, R; Villa, R; Zaffaroni, N, 1994) |
| "A multi-institutional cooperative study of patients with locally advanced, recurrent, or metastatic gastric adenocarcinoma who had not previously received chemotherapy was conducted, prospectively randomizing patients to receive either doxorubicin or the three-drug combination, 5-fluorouracil (5-FU), doxorubicin (Adriamycin; Adria Laboratories, Columbus, Ohio), and BCNU (FAB)." | 5.06 | Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies. ( Fox, RM; Gill, G; Levi, JA; Tattersall, MH; Thomson, D; Woods, RL, 1986) |
| "Thirty-two evaluable patients with advanced measurable gastric adenocarcinoma were treated with a combination of 5-fluorouracil, adriamycin, and BCNU (FAB)." | 5.05 | 5-fluorouracil, adriamycin, and BCNU (FAB) combination chemotherapy for advanced gastric cancer. ( Di Lauro, L; Lopez, M; Papaldo, P; Perno, CF, 1984) |
| " The addition of a nitrosourea appears to be an improvement over cyclophosphamide used alone in oat cell carcinoma and over the two drug combination of cyclophosphamide and methotrexate in both adenocarcinoma of the lung and oat cell disease." | 5.04 | Nitrosourea combinations in lung cancer. ( Livingston, RB, 1976) |
| "In a prospective, multi-centre, randomized study of 109 patients with metastatic gastro-intestinal adenocarcinomas the response rate, survival time and side-effects of two drug combinations, carmustin +5-fluorouracil and carmustin + ftorafur, were compared (same carmustin dosage in both groups)." | 5.04 | [A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)]. ( Arnold, H; Drings, P; Geldmacher, J; Hartwich, G; Kredel, L; Mayer, M; Neidhardt, B; Queisser, W; Rösch, W; Schaefer, J; von Oldershausen, HF; Wahrendorf, J, 1979) |
| "The ability of lonidamine (LND), an energolytic derivative of indazole carboxylic acid, to modulate the cytotoxic activity of mitomycin C (MMC) and 1,3,bis(2-chloroethyl)-1-nitrosourea (BCNU) was investigated in two human adenocarcinoma cell lines (LoVo and HT29) expressing different sensitivity profiles to the drugs." | 3.69 | In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells. ( Bearzatto, A; Costa, A; Orlandi, L; Silvestrini, R; Villa, R; Zaffaroni, N, 1994) |
| "Between 2/87 and 2/91, 49 women with operable breast cancer involving greater than or equal to 10 axillary nodes were treated following mastectomy, with four cycles of Cyclophosphamide, Adriamycin, 5FU, followed by high doses of Cyclophosphamide, Cisplatin, Carmustine (HDCT) with autologous bone marrow transplant support." | 3.68 | Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B. ( Halperin, EC; Marks, LB; Peters, W; Prosnitz, LR; Rosner, GL; Ross, M; Vredenburgh, JJ, 1992) |
| "21 patients with metastatic breast cancer, refractory to conventional agents, were treated with a combination of BCNU, vincristine, mitomycin-C and prednisone given every 4 weeks." | 3.67 | Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study. ( Anderson, P; DiBella, NJ; Fink, K; Garfield, D; Murphy, J; Speer, J, 1984) |
| "Thirty-five patients with advanced-stage metastatic or unresectable gastric adenocarcinoma were given combination chemotherapy consisting of fluorouracil, doxorubicin, and 1,3-bis (2-chlorbethyl)-1-nitrosourea." | 3.66 | Improved combination chemotherapy in advanced gastric cancer. ( Aroney, RS; Dalley, DN; Levi, JA, 1979) |
| "originates in the stomach." | 2.64 | Gastric cancer: current status of treatment. ( Carter, SK; Comis, RL, 1977) |
| "The aim of this study was to determine the efficacy of 252Californium neutron intracavitary brachytherapy using a two-channel Y applicator combined with external beam radiotherapy for the treatment of endometrial cancer." | 1.43 | Clinical assessment of 252Californium neutron intracavitary brachytherapy using a two-channel Y applicator combined with external beam radiotherapy for endometrial cancer. ( Chen, S; Lei, X; Tang, C; Xiong, YL; Xu, WJ; Zhao, KW; Zhou, Q, 2016) |
| "Cyclocreatine was not very cytotoxic upon 24 h of exposure of human SW2 small-cell lung cancer cells to concentrations of up to 5 mM." | 1.29 | Cyclocreatine in cancer chemotherapy. ( Kaddurah-Daouk, R; Kufe, DW; Liu, J; Menon, K; Northey, D; Teicher, BA, 1995) |
| "Twenty-two advanced consecutive thyroid cancer patients with varying histologies were treated with the so called BAP regime which consisted of bleomycin (B) 30 mg a day for three days, adriamycin (A) 60 mg/m2 iv in day 5, and cisplatinum (P) 60 to mg/m2 iv in day 5." | 1.28 | Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. ( Busnardo, B; Casara, D; De Besi, P; Fiorentino, MV; Girelli, ME; Nacamulli, D; Simioni, N; Toso, S; Zorat, P, 1991) |
| "In the MCF-7 human breast cancer cell line and in the MCF-7/CP (CDDP resistant) subline, U73-975 and mitoxantrone were both potent cytotoxic agents (IC50 0." | 1.28 | Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells. ( Ayash, L; Herman, TS; Korbut, T; Teicher, BA, 1991) |
| "Melphalan was administered as a bolus oral dose, using 2-mg tablets." | 1.28 | Pharmacokinetics of very high-dose oral melphalan in cancer patients. ( Alberts, DS; Asbury, RF; Boros, L; Goodman, TL; Hickox, DE; Peng, YM; Penn, TE, 1990) |
| "Metronidazole, 1." | 1.27 | Feasibility study of combining metronidazole with chemotherapy. ( Bélanger, R; Crook, AF; Heringer, R; Hopkins, HS; Hugenholtz, H; Maroun, JA; Richard, MT; Stewart, DJ; Yan, RC; Young, V, 1983) |
| "AC = adriamycin and cyclophosphamide in ovarian cancer." | 1.27 | Polychemotherapy in ovarian cancer: treatment with Adriamycin, BCNU and cyclophosphamide vs. Adriamycin and cyclophosphamide. ( Amunni, G; Bonazza, M; Branconi, F; Massi, GB; Mazzei, T; Scarselli, G, 1984) |
| "Seventeen patients with metastatic breast cancer were treated with a high-dose combination chemotherapy regimen and autologous bone marrow support." | 1.27 | High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. ( Andersen, J; Antman, K; Come, S; Eder, JP; Elias, A; Henner, WD; Peters, W; Schnipper, L; Schryber, S; Shea, T, 1986) |
| "Thirty-one patients with metastatic brain tumors (MBT) from lung cancer and ten patients with MBT from melanoma received BCNU, 100 mg/m2, every four weeks by intracarotid and/or vertebral artery infusion into each involved site." | 1.26 | Phase II study--intra-arterial BCNU therapy for metastatic brain tumors. ( Avellanosa, AM; Caracandas, J; Ghoorah, J; Jennings, E; Karakousis, C; Madajewicz, S; Park, HC; Takita, H; Vincent, R; West, CR, 1981) |
| "A significant decrease in the number of metastases was observed in the triple drug therapy, administered for three cycles, BCNU only, and BCNU and adriamycin." | 1.26 | Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III. ( Drago, JR; Worgul, TJ, 1981) |
| "Skin, lymph node, and soft tissue metastases more frequently responded to therapy, while hepatic, peritoneal, and osseous metastases responded with an intermediate frequency." | 1.26 | Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma. ( Klahr, C; Presant, CA; Van Amburg, A, 1977) |
| "Osseous, visceral, and cutaneous metastases responded equally well." | 1.26 | Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumors. ( Klahr, C; Kolhouse, JF; Presant, CA, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (76.92) | 18.7374 |
| 1990's | 11 (16.92) | 18.2507 |
| 2000's | 2 (3.08) | 29.6817 |
| 2010's | 2 (3.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabezas-Camarero, S | 1 |
| de la Orden García, V | 1 |
| García-Barberán, V | 1 |
| Mediero-Valeros, B | 1 |
| Subhi-Issa, AI | 1 |
| Llovet García, P | 1 |
| Bando-Polaino, I | 1 |
| Merino Menéndez, S | 1 |
| Pérez-Segura, P | 1 |
| Díaz-Rubio, E | 1 |
| Zhou, Q | 1 |
| Tang, C | 1 |
| Zhao, KW | 1 |
| Xiong, YL | 1 |
| Chen, S | 1 |
| Xu, WJ | 1 |
| Lei, X | 1 |
| Beech, DJ | 1 |
| Madan, AK | 1 |
| Aliabadi-Wahle, S | 1 |
| Hays, AN | 1 |
| Long, WP | 1 |
| Presant, CA | 5 |
| Hillinger, S | 1 |
| Klahr, C | 3 |
| Madajewicz, S | 1 |
| West, CR | 1 |
| Park, HC | 1 |
| Ghoorah, J | 1 |
| Avellanosa, AM | 1 |
| Takita, H | 1 |
| Karakousis, C | 1 |
| Vincent, R | 1 |
| Caracandas, J | 1 |
| Jennings, E | 1 |
| Lopez, M | 2 |
| Perno, CF | 1 |
| Di Lauro, L | 2 |
| Papaldo, P | 1 |
| Stewart, DJ | 1 |
| Maroun, JA | 1 |
| Young, V | 1 |
| Crook, AF | 1 |
| Hopkins, HS | 1 |
| Yan, RC | 1 |
| Richard, MT | 1 |
| Hugenholtz, H | 1 |
| Bélanger, R | 1 |
| Heringer, R | 1 |
| DiBella, NJ | 1 |
| Garfield, D | 1 |
| Fink, K | 1 |
| Anderson, P | 1 |
| Speer, J | 1 |
| Murphy, J | 1 |
| Rubin, J | 1 |
| Schutt, AJ | 3 |
| O'Connell, MJ | 1 |
| Gertz, MA | 1 |
| Moertel, CG | 4 |
| Mazzei, T | 1 |
| Bonazza, M | 1 |
| Amunni, G | 1 |
| Scarselli, G | 1 |
| Branconi, F | 1 |
| Massi, GB | 1 |
| Heim, ME | 1 |
| Swoboda, M | 1 |
| Pahlke, W | 1 |
| Edler, L | 1 |
| Bicker, U | 1 |
| Bartolucci, A | 2 |
| Gunderson, LL | 1 |
| Hoskins, RB | 1 |
| Cohen, AC | 1 |
| Kaufman, S | 1 |
| Wood, WC | 1 |
| Carey, RW | 1 |
| Rosso, R | 1 |
| Nobile, MT | 1 |
| Brema, F | 1 |
| Porcile, G | 1 |
| Cinquegrana, A | 1 |
| De Palma, M | 1 |
| Rubagotti, A | 1 |
| Gropp, C | 1 |
| Havemann, K | 1 |
| Denes, AE | 1 |
| Veronesi, A | 1 |
| Tirelli, U | 1 |
| Galligioni, E | 1 |
| Trovò, MG | 1 |
| Crivellari, D | 1 |
| Donatella Magri, M | 1 |
| Roncadin, M | 1 |
| Tumolo, S | 1 |
| Grigoletto, E | 1 |
| Cowen, DM | 1 |
| Siegerstetter, J | 1 |
| Janik, AC | 1 |
| Double, JA | 1 |
| Drago, JR | 2 |
| Goldman, LB | 1 |
| Worgul, T | 1 |
| Gershwin, ME | 1 |
| Giuliani, FC | 1 |
| Zirvi, KA | 2 |
| Kaplan, NO | 1 |
| Goldin, A | 1 |
| Schmitz, R | 3 |
| Hüper, J | 1 |
| Pichlmayr, R | 1 |
| Worgul, TJ | 1 |
| Villa, R | 1 |
| Zaffaroni, N | 1 |
| Orlandi, L | 1 |
| Bearzatto, A | 1 |
| Costa, A | 1 |
| Silvestrini, R | 1 |
| Teicher, BA | 2 |
| Menon, K | 1 |
| Northey, D | 1 |
| Liu, J | 1 |
| Kufe, DW | 1 |
| Kaddurah-Daouk, R | 1 |
| Najjar, TA | 1 |
| Slomiany, BL | 1 |
| Kokkinakis, DM | 1 |
| Ahmed, MM | 1 |
| Delgado, R | 1 |
| Fruitwala, MM | 1 |
| Mohiuddin, M | 1 |
| Albores-Saavedra, J | 1 |
| Cagnoni, PJ | 1 |
| Nieto, Y | 1 |
| Shpall, EJ | 1 |
| Bearman, SI | 1 |
| Barón, AE | 1 |
| Ross, M | 2 |
| Matthes, S | 1 |
| Dunbar, SE | 1 |
| Jones, RB | 1 |
| Alarcon, K | 1 |
| Demeunynck, M | 1 |
| Lhomme, J | 1 |
| Carrez, D | 1 |
| Croisy, A | 1 |
| Sufrin, G | 1 |
| Murphy, GP | 1 |
| Livingston, RB | 1 |
| Queisser, W | 1 |
| Schaefer, J | 1 |
| Arnold, H | 1 |
| Drings, P | 1 |
| Geldmacher, J | 1 |
| Hartwich, G | 1 |
| Kredel, L | 1 |
| Mayer, M | 1 |
| Neidhardt, B | 1 |
| von Oldershausen, HF | 1 |
| Rösch, W | 1 |
| Wahrendorf, J | 1 |
| Carter, SK | 5 |
| Comis, RL | 3 |
| Levi, JA | 2 |
| Dalley, DN | 1 |
| Aroney, RS | 1 |
| Falkson, G | 1 |
| van Eden, EB | 1 |
| Van Amburg, A | 1 |
| Slavik, M | 1 |
| Jochimsen, PR | 1 |
| Pearlman, NW | 1 |
| Lawton, RL | 1 |
| Kolhouse, JF | 1 |
| Marks, LB | 1 |
| Halperin, EC | 1 |
| Prosnitz, LR | 1 |
| Vredenburgh, JJ | 1 |
| Rosner, GL | 1 |
| Peters, W | 2 |
| Natali, M | 1 |
| Tonini, G | 1 |
| Carpano, S | 1 |
| Vici, P | 1 |
| Conti, EM | 1 |
| De Besi, P | 1 |
| Busnardo, B | 1 |
| Toso, S | 1 |
| Girelli, ME | 1 |
| Nacamulli, D | 1 |
| Simioni, N | 1 |
| Casara, D | 1 |
| Zorat, P | 1 |
| Fiorentino, MV | 1 |
| Ayash, L | 1 |
| Korbut, T | 1 |
| Herman, TS | 1 |
| Ushio, Y | 1 |
| Arita, N | 1 |
| Hayakawa, T | 1 |
| Mogami, H | 1 |
| Hasegawa, H | 1 |
| Bitoh, S | 1 |
| Oku, Y | 1 |
| Ikeda, H | 1 |
| Kanai, N | 1 |
| Kanoh, M | 1 |
| Boros, L | 1 |
| Peng, YM | 1 |
| Alberts, DS | 1 |
| Asbury, RF | 1 |
| Goodman, TL | 1 |
| Penn, TE | 1 |
| Hickox, DE | 1 |
| Atassi, G | 1 |
| Dumont, P | 1 |
| Gosse, C | 1 |
| Fournier, JP | 1 |
| Gouyette, A | 1 |
| Roger, P | 1 |
| Köhler, L | 1 |
| Mennigen, R | 1 |
| Fuchshuber, P | 1 |
| Eypasch, E | 1 |
| Blöchl, H | 1 |
| Schröder, U | 1 |
| Seidenfeld, J | 2 |
| Barnes, D | 1 |
| Block, AL | 1 |
| Erickson, LC | 1 |
| Schaefer, EL | 1 |
| Morimoto, RI | 1 |
| Theodorakis, NG | 1 |
| Fox, RM | 1 |
| Tattersall, MH | 1 |
| Woods, RL | 1 |
| Thomson, D | 1 |
| Gill, G | 1 |
| Eder, JP | 1 |
| Antman, K | 1 |
| Henner, WD | 1 |
| Elias, A | 1 |
| Shea, T | 1 |
| Schryber, S | 1 |
| Andersen, J | 1 |
| Come, S | 1 |
| Schnipper, L | 1 |
| Schlag, P | 1 |
| Bukowski, RM | 1 |
| Theodors, A | 1 |
| Purvis, JD | 1 |
| Budd, GT | 1 |
| Weick, JK | 1 |
| Gahbauer, R | 1 |
| Facchini, V | 1 |
| Gadducci, A | 1 |
| Bogi, G | 1 |
| Colombi, L | 1 |
| Basile, AG | 1 |
| Ballantini, M | 1 |
| De Pasquale, F | 1 |
| Fioretti, P | 1 |
| Marsh, JC | 1 |
| DeConti, RC | 1 |
| Hubbard, SP | 1 |
| Tormey, DC | 1 |
| Gailani, S | 1 |
| Leone, L | 1 |
| Schabel, FM | 1 |
| Broder, LE | 1 |
| Johnston, TP | 1 |
| Reitemeier, RJ | 2 |
| Hahn, RG | 2 |
| Omura, GA | 1 |
| Roberts, GA | 1 |
| Kovach, JS | 1 |
| Lokich, J | 1 |
| Chawla, PL | 1 |
| Brooks, J | 1 |
| Frei, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for carmustine and Adenocarcinoma
| Article | Year |
|---|---|
The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carmustine; Drug Therapy, Combination; Female; F | 1975 |
A review of chemotherapy in gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Chlorambucil; Chromomycins; Cyclophosphamide; Cyt | 1974 |
1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma; Carmustine; Cell Line; Cell-Free System; | 1972 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Br | 1973 |
10 trials available for carmustine and Adenocarcinoma
| Article | Year |
|---|---|
5-fluorouracil, adriamycin, and BCNU (FAB) combination chemotherapy for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine | 1984 |
Randomized trial of chemoimmunotherapy in advanced non-oat-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; BCG Vaccine; Carcinoma, Squamous Cell; Carmustine; Clinical Trials as T | 1982 |
Nitrosourea combinations in lung cancer.
Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carmustine; Clinical Trials as Topi | 1976 |
[A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)].
Topics: Adenocarcinoma; Carmustine; Fluorouracil; Gastrointestinal Neoplasms; Humans; Intestinal Neoplasms; | 1979 |
Gastric cancer: current status of treatment.
Topics: Adenocarcinoma; Aged; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Ther | 1977 |
A controlled clinical trial of fluorouracil plus imidazole carboxamide dimethyl triazeno plus vincristine plus bis-chloroethyl nitrosourea plus radiotherapy in stomach cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Dacarbazin | 1976 |
Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Carcinom | 1991 |
Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Tr | 1986 |
Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adolescent; Adrenal Gland Neoplasms; Adult; Alkylating Agents; | 1971 |
1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma; Carmustine; Cell Line; Cell-Free System; | 1972 |
52 other studies available for carmustine and Adenocarcinoma
| Article | Year |
|---|---|
Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Che | 2019 |
Clinical assessment of 252Californium neutron intracavitary brachytherapy using a two-channel Y applicator combined with external beam radiotherapy for endometrial cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Californ | 2016 |
Synchronous occurrence of glioblastoma multiforme and esophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplat | 2003 |
Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Amphotericin B; Bone Marrow; Carcinoma, Bronchogenic; Carcinoma, Small | 1980 |
Phase II study--intra-arterial BCNU therapy for metastatic brain tumors.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carmu | 1981 |
Feasibility study of combining metronidazole with chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Sq | 1983 |
Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmu | 1984 |
A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Carmusti | 1984 |
Polychemotherapy in ovarian cancer: treatment with Adriamycin, BCNU and cyclophosphamide vs. Adriamycin and cyclophosphamide.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; | 1984 |
Treatment of autochthonous rat colonic adenocarcinomas with a thioether-lysophospholipid derivative in mono- and combination chemotherapy.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemot | 1984 |
Adriamycin, BCNU, and cyclophosphamide in drug-resistant adenocarcinoma of the ovary.
Topics: Adenocarcinoma; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cycloph | 1983 |
Combined modality treatment of gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Drug Therap | 1983 |
[Chemotherapy of stomach cancer].
Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Cisplatin; Doxorubicin; Drug Administration Sched | 1982 |
Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Topics: Adenocarcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Carmustine; Cyclophosphamide; Dox | 1982 |
Third-line chemotherapy with mitomycin, vinblastine, and carmustine (BCNU) in refractory breast carcinoma: a pilot study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carmustine; Drug Administratio | 1982 |
The assessment of response of murine transplantable colon tumors to combination chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carmustine; Cell Line; Colonic Neoplasms; Dimethylhy | 1982 |
Therapy for Nb rat tumor transplanted in athymic mice.
Topics: Adenocarcinoma; Androgens; Animals; Carmustine; Dactinomycin; Male; Mice; Mice, Nude; Neoplasm Metas | 1981 |
Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin.
Topics: Adenocarcinoma; Animals; Carmustine; Colonic Neoplasms; Doxorubicin; Fluorouracil; Humans; Mice; Mic | 1981 |
Studies in an animal model on the effectiveness of adjuvant chemotherapy with 5-FU and BCNU in cases of colorectal adenocarcinoma.
Topics: Adenocarcinoma; Animals; Carmustine; Colonic Neoplasms; Drug Therapy, Combination; Female; Fluoroura | 1981 |
Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III.
Topics: Adenocarcinoma; Animals; Carmustine; Cyclophosphamide; Doxorubicin; Drug Combinations; Drug Therapy, | 1981 |
In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Cell Cycle; Cell Survival; Colonic Neoplasms; Dos | 1994 |
Cyclocreatine in cancer chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Carmustine; Cell Division; Ce | 1995 |
Sensitivity of human colon tumor metastases to anticancer drugs in athymic (nude) mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Doxorubicin; Female; | 1993 |
Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Apoptosis; Carmustine; Cell Survival | 1997 |
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; | 1998 |
Potentiation of BCNU cytotoxicity by molecules targeting abasic lesions in DNA.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Carmustine; Cattle; DNA; Humans; Leukemi | 2001 |
Pharmacokinetic studies of a transplantable murine renal adenocarcinoma.
Topics: Adenocarcinoma; Animals; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Eval | 1977 |
Improved combination chemotherapy in advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Carmustine; Doxorubicin; Drug Therapy, Combination; Female; Fluorouraci | 1979 |
Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Ascites; Bone Neoplasms; Breast Neoplasms; Carmustine; | 1977 |
Clinical studies with nitrosoureas in various solid tumors.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Squamous Cell; Carmustine; Female; Genital Neoplasms, F | 1976 |
Pancreatic carcinoma as a sequel to therapy of lymphoma.
Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Agents; Carmustine; Cyclophosphamide; Female; Hodg | 1976 |
Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumors.
Topics: Adenocarcinoma; Adolescent; Aged; Breast Neoplasms; Carcinoma, Squamous Cell; Carmustine; Cyclophosp | 1976 |
Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; | 1992 |
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Epirubicin; | 1990 |
Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.
Topics: Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethas | 1991 |
Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Benzofurans; Brea | 1991 |
Pharmacokinetics of very high-dose oral melphalan in cancer patients.
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Biologi | 1990 |
Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Dose-Response Relatio | 1989 |
Treatment with 5-FU, VCR and BCNU in tumor bearing nude mice.
Topics: Adenocarcinoma; Animals; Carmustine; Colorectal Neoplasms; Female; Fluorouracil; Humans; Mice; Mice, | 1989 |
Human-alpha-interferon on xenotransplanted human colonic adenocarcinomas in nude mice.
Topics: Adenocarcinoma; Animals; Carmustine; Colonic Neoplasms; Female; Fluorouracil; Humans; Interferon Typ | 1989 |
Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells.
Topics: Adenocarcinoma; Carmustine; Cell Survival; Cells, Cultured; DNA Damage; DNA, Neoplasm; Eflornithine; | 1987 |
Chemical specificity for induction of stress response genes by DNA-damaging drugs in human adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Cell Line; Colonic Neoplasms; DNA Damage; Genes; | 1988 |
High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Trans | 1986 |
Adjuvant chemotherapy in gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality | 1987 |
Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carm | 1987 |
Polychemotherapy with carmustine, cyclophosphamide plus adriamycin in the treatment of advanced ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; | 1985 |
Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
Topics: Adenocarcinoma; Administration, Oral; Carmustine; Colonic Neoplasms; Diarrhea; Fluorouracil; Hematoc | 1974 |
Treatment of the patient with adenocarcinoma of unknown origin.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Autopsy; Carmustine; Female; Fluorouracil; Human | 1972 |
Combination therapy of solid tumors using 1,3-bis(2-chloroethyl)-1-nitrosourea (NCNU), vincristine, methotrexate, and 5-fluorouracil.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Carmustine; Female; Fluorouracil; Gastrointes | 1973 |
Therapy of advanced gastrointestinal cancer with the nitrosoureas.
Topics: Adenocarcinoma; Antineoplastic Agents; Bone Marrow Diseases; Carmustine; Colonic Neoplasms; Cyclohex | 1973 |
Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer.
Topics: Adenocarcinoma; Carmustine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukopenia; Mal | 1974 |
Chemotherapy in pancreatic carcinoma: 5 fluorouracil (5FU) and 1,3 bis-(2 chloretjyl)-1-nitrosourea (BCNU).
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Carmustine; Drug Therapy, Combination; Evaluation Studies as To | 1974 |